See how we partnered with a major pharma company to develop a collaborative change management strategy and clear communication plan.
Health
NEW REPORT
Understand the steps brands can take to stay relevant in tough times
Life Sciences is in hyperdrive. The breakneck pace of innovation is saving millions of lives. Yet many challenges remain the same. How to balance the needs of patients and providers with the demands of regulators and stakeholders? How to lead with science while listening to human experience? Escalent’s deep healthcare and life sciences insights and agile implementation model help the innovators of today become the market leaders of tomorrow.
Escalent is a leading, global life sciences and healthcare market research and consulting firm. We know the players, the trends, and the policies that drive change across the health ecosystem. From big pharmaceutical companies to small biotech. From medical suppliers and device manufacturers to hospitals and healthcare providers.
The leaders of tomorrow need a holistic life sciences consulting partner. We support clients across the entire product lifecycle—from pre-clinical innovation to commercialization and post-launch tracking. You can expect seasoned medical consultants, data scientists, and insights practitioners with a passion for your industry. Let us help you accelerate the development process from molecule to brand launch and beyond.
Staying on top means juggling multiple priorities. Where can you expand, what challenges will you face, and how will you succeed? We partner with growing healthcare firms to deliver nuanced market assessments, competitive intelligence, and M&A support. Whether it’s quick-turn intelligence or ongoing monitoring, find out where to play and how to win with innovative healthcare and life sciences market research and consulting from Escalent.
Show me moreLife sciences and healthcare are facing significant changes, from meeting patient needs to developing new treatments. Escalent is behind the household names known for trusted care—our healthcare and life sciences market research and analysis defines, shapes and evaluates your brand and our strategies optimize your messaging on a personal level to make powerful connections with patients and HCPs. Let us help future proof your most powerful asset.
Show me moreInnovation is the name of the game in life sciences and healthcare. Escalent partners with the world’s largest healthcare and pharmaceutical companies, leveraging market research to identify the next big opportunity—whether it’s evaluating and prioritizing novel assets or understanding epidemiology. Clients rely on our healthcare insights, strategy, consulting and implementation expertise to position them for success.
Show me moreFacing tight timelines but your team is consumed by non-core tasks? Trying to stay on top of the latest innovations? Escalent provides a dedicated team of healthcare and life sciences Implementation Consultants as researchers and analysts to provide ongoing support. We act like an extension of your team without the headaches of headcount approval, hiring, onboarding, or training. Work smarter and move faster with Escalent.
Show me moreThe customer journey is evolving. Download our guide to boosting customer growth using its award-winning path-to-purchase research.
Normative databases are useful in market research, but like any tool, come with their own set of limitations that are often not fully acknowledged or recognized. Here’s what to look out for.
When you are in the business of saving millions of lives each year, it’s no surprise that healthcare entities leverage external consultative support to help make critical decisions. But how much return are pharma companies getting from their strategic consulting spend?
Top data analytics and advisory firm Escalent announces it has acquired C Space and Hall & Partners.
Escalent's Tech TrustBuilder is a scientifically-validated framework that measures trust in technology to help brands build bonds with people
Escalent's ISO/IEC 27001 certification is one way we maintain rigorous vigilance on the global regulatory landscape
